FHTX vs FTV · rev $22.6M vs P/E 31, rev $6.23B
Foghorn Therapeutics Inc (FHTX) versus Fortive Corp (FTV) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
FHTX currently screens at market cap $237.8M. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Not investment advice. Open the FHTX and FTV stock pages for the full models.
Not investment advice.